Patents Assigned to NEUROVATION LABS, INC.
  • Compositions and methods to detect GLUA1 in brain and to identify the presence of GLUA1-mediated post-traumatic stress disorder and other neurological disorders
    Patent number: 11439715
    Abstract: The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing GluA1-mediated disorders, such as PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing such imaging techniques using the compositions, to identify elevated GluA1 expression or activity in a subject.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 13, 2022
    Assignee: Neurovation Labs, Inc.
    Inventor: Jennifer Nicole Perusini
  • Compositions and methods to detect GluA1 in brain and to identify the presence of GluA1-mediated PTSD
    Patent number: 11224668
    Abstract: The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing such imaging techniques using the compositions, to identify elevated GluA1 expression or activity in a subject, which is a biological marker of PTSD.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: January 18, 2022
    Assignee: NEUROVATION LABS, INC.
    Inventor: Jennifer Perusini
  • COMPOSITIONS AND METHODS TO DETECT GLUA1 IN BRAIN AND TO IDENTIFY THE PRESENCE OF GLUA1-MEDIATED PTSD
    Publication number: 20190038783
    Abstract: The present invention provides compositions and methods for detecting GluA1, as a subunit protein and/or as a GluA1-containing, GluA2-lacking AMPAR complex. The invention further provides composition and methods for detecting and/or diagnosing PTSD. The invention further relates to compositions that can be detected using radiological imaging techniques, and processes for performing such imaging techniques using the compositions, to identify elevated GluA1 expression or activity in a subject, which is a biological marker of PTSD.
    Type: Application
    Filed: February 27, 2017
    Publication date: February 7, 2019
    Applicant: NEUROVATION LABS, INC.
    Inventor: Jennifer Nicole Perusini